These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10682955)

  • 1. The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society.
    J Am Geriatr Soc; 2000 Feb; 48(2):224-7. PubMed ID: 10682955
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.
    American Geriatrics Society Clinical Practice Committee
    J Am Geriatr Soc; 2002 Aug; 50(8):1439-45; discussion 1446-7. PubMed ID: 12165003
    [No Abstract]   [Full Text] [Related]  

  • 3. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will direct oral anticoagulants completely replace warfarin?
    Thachil J
    Br J Hosp Med (Lond); 2018 Nov; 79(11):604-605. PubMed ID: 30418820
    [No Abstract]   [Full Text] [Related]  

  • 6. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines on oral anticoagulation with warfarin - fourth edition.
    Keeling D; Baglin T; Tait C; Watson H; Perry D; Baglin C; Kitchen S; Makris M;
    Br J Haematol; 2011 Aug; 154(3):311-24. PubMed ID: 21671894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Outpatient anticoagulation].
    Pötzsch B
    MMW Fortschr Med; 2014 May; 156(9):48-53; quiz 54-5. PubMed ID: 24908890
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.
    Lemos Silva R; Carvalho de Sousa J; Calisto C; Braz Nogueira JM; Ravara L
    Rev Port Cardiol; 2007; 26(7-8):769-88. PubMed ID: 17939586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 13. The economics of anticoagulation: what are the issues?
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S292-6. PubMed ID: 15605699
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.
    Uchiyama S
    Intern Med; 2001 Dec; 40(12):1166-7. PubMed ID: 11813834
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation.
    Key N
    Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
    Hirsh J; Dalen J; Anderson DR; Poller L; Bussey H; Ansell J; Deykin D
    Chest; 2001 Jan; 119(1 Suppl):8S-21S. PubMed ID: 11157640
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for oral anticoagulants.
    J Assoc Physicians India; 2014 Jun; 62(6 Suppl):19-27. PubMed ID: 25845124
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin: better the devil you know.
    Blockman M
    Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543
    [No Abstract]   [Full Text] [Related]  

  • 20. Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug.
    Prescrire Int; 2015 Jun; 24(161):150. PubMed ID: 26436165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.